Search

everythinglearnresearchcommunity

for

Search:↓

Most hospitalized COVID-19 patients had long-term symptoms like fatigue and hair loss, with women and those sicker during hospitalization at higher risk.

Laser treatment increases hair density and thickness safely in women with hair loss.

Existing drug dexamethasone may lower death risk in severe COVID-19 cases; more research needed for other drugs.

Hair loss from COVID-19 usually starts around 45 days after infection and lasts about 47.5 days.

Hirsute women have lower type 2 17β-HSD enzyme levels, which improve with treatment.

Testosterone may have a dual role in COVID-19, potentially worsening outcomes in men, and testosterone therapy could help some patients, but more research is needed.

Mesenchymal stromal cells may help treat severe COVID-19, but more research is needed to confirm their effectiveness.

COVID-19 may cause hair loss and scalp pain due to inflammation and changes in hair follicle receptors, but these symptoms typically resolve in 2 to 4 months.

DA-9401 helps protect rat testis from finasteride damage.

The gene SDR5A1 is found in scalp hair of both hirsute and normal individuals, but it does not explain differences in hair growth.

COVID-19 and hypopituitarism (reduced pituitary gland function) are linked, with the latter's related health issues potentially worsening COVID-19 outcomes, and COVID-19 possibly increasing risk for pituitary complications.

Finasteride may not stop severe hair loss after stopping minoxidil.

The article suggests using safety measures and telemedicine for aesthetic dermatology during COVID-19, while some procedures can still be done safely.

Possible link between androgens and COVID-19 severity; more research needed.

Transtherapy significantly improved moderate to severe acne scars without side effects.

Certain genetic differences may affect how likely someone is to get COVID-19 and how severe it might be.

Sardinians were historically short due to a mix of genetics and factors like disease and poor nutrition, but recent height increases suggest better living conditions had a bigger impact.

Frequent use of hair straighteners can cause hair loss similar to scarring alopecia in young Turkish women.

A woman's hair loss after COVID-19 was likely due to a mix of pressure-induced alopecia and acute telogen effluvium.

The treatment with an oral drug and topical lotion is effective and well-tolerated for hair loss after COVID-19.

Women with PCOS have a higher risk of metabolic syndrome and need lifestyle changes and treatment.

Mesotherapy is a promising alternative to minoxidil for hair loss with mild side effects.

Covid-19 can cause hair loss due to immune and psychological factors.

COVID-19 can cause hair loss, but specialists can help treat it.

Ayurvedic treatment helped a woman with PCOS resume regular periods and improve symptoms without side effects.

The botanical shampoo with Morus alba root extract is safe and effective for treating hair loss.

Androgens may worsen COVID-19 and hair loss could indicate the disease's severity.

COVID-19 may be linked to hair loss called Telogen Effluvium, affecting quality of life and self-esteem.

A woman lost over 80% of her hair due to a condition called telogen effluvium after having COVID-19.

COVID-19 protective measures led to skin irritation, hair loss, and brittle nails; using skin-friendly products and a healthy diet is recommended.